SOX2 and Alzheimer disease: The ability of melatonin to upregulate Sox2, Oct4, and Nanog in normal and diseased conditions unravels its potential in enhancing neurogenesis and cell reprogramming in line with preventive and therapeutic approach towards aging and AD.